一项皮肤科医生调查:浅部真菌感染的诊断——用于启动治疗和评估疗效的方法与需求
该调查通过在线问卷向62名对真菌学和甲病感兴趣的皮肤科医生发放,其中38名(61%)完成全部问卷。结果显示,82%-100%的受访者认为理想情况下应结合直接镜检(或组织学)与针对菌属/菌种的靶向治疗;多数医生在疗效评估时采用临床评估联合直接镜检,且此阶段更看重真菌活力;分子学方法并非所有受访者可用。结论指出诊断方法异质且使用情况因实践和国家而异,皮肤科医生认为在开始口服抗真菌治疗前进行真菌学诊断以确认诊断并按菌属和菌种靶向治疗很重要。
要点
- 82%-100%的受访皮肤科医生认为理想情况下应使用直接镜检(或组织学)联合针对菌属/菌种的靶向治疗。
- 多数皮肤科医生在疗效评估时使用临床评估联合直接镜检,且此阶段比启动治疗时更重视真菌活力。
- 分子学方法并非所有受访者可用;诊断方法的使用因实践和国家而异。
核心结论
- 皮肤科医生认为在开始口服抗真菌治疗前进行真菌学诊断以确认诊断并按菌属和菌种靶向治疗很重要。
研究设计与样本
- 在线问卷发放给EADV真菌学工作组及其他对真菌学和甲病感兴趣的皮肤科医生。
- 问卷发放给62名皮肤科医生,其中38名(61%)完成全部问卷、7名(11%)部分完成、17名(27%)未回复。
主要发现
- 82%-100%的受访者表示理想情况下会使用直接镜检(或组织学)联合针对甲真菌病、皮肤癣菌病、念珠菌相关感染和马拉色菌相关感染的菌属/菌种靶向治疗。
- 多数皮肤科医生在疗效评估时使用临床评估联合直接镜检,且此阶段比启动治疗时更重视真菌活力。
- 分子学方法并非所有受访者可用。
关键数值与推荐
- 82%-100%的受访者表示理想情况下会使用直接镜检(或组织学)联合针对甲真菌病、皮肤癣菌病、念珠菌相关感染和马拉色菌相关感染的菌属/菌种靶向治疗。
- 多数皮肤科医生在疗效评估时使用临床评估联合直接镜检,且此阶段比启动治疗时更重视真菌活力。
临床怎么用
- 皮肤科医生认为在开始口服抗真菌治疗前进行真菌学诊断以确认诊断并按菌属和菌种靶向治疗很重要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Superficial fungal infections are common. It is important to confirm the clinical diagnosis by mycological laboratory methods before initiating systemic antifungal treatment, especially as antifungal sensitivity and in vitro susceptibility may differ between different genera and species. For many years, the gold standard for diagnosis of superficial fungal infections has been direct fungal detection in the clinical specimen (microscopy) supplemented by culturing. Lately, newer molecular based methods for fungal identification have been developed. OBJECTIVE: This study was initiated to focus on the current usage of mycological diagnostics for superficial fungal infections by dermatologists. It was designed to investigate whether it was necessary to differentiate between initial diagnostic tests and those used at treatment follow-up in specific superficial fungal infections. METHODS: An online questionnaire was distributed among members of the EADV mycology Task Force and other dermatologists with a special interest in mycology and nail disease. RESULTS: The survey was distributed to 62 dermatologists of whom 38 (61%) completed the whole survey, 7 (11%) partially completed and 17 (27%) did not respond. Nearly, all respondents (82-100%) said that ideally they would use the result of direct microscopy (or histology) combined with a genus/species directed treatment of onychomycosis, dermatophytosis, Candida- and Malassezia-related infections. The majority of the dermatologists used a combination of clinical assessment and direct microscopy for treatment assessment and the viability of the fungus was considered more important at this visit than when initiating the treatment. Molecular based methods were not available for all responders. CONCLUSION: The available diagnostic methods are heterogeneous and their usage differs between different practices as well as between countries. The survey confirmed that dermatologists find it important to make a mycological diagnosis, particularly prior to starting oral antifungal treatment in order to confirm the diagnose and target the therapy according to genus and species.
引用
- Saunte DML, Piraccini BM, Sergeev AY, et al. A survey among dermatologists: diagnostics of superficial fungal infections - what is used and what is needed to initiate therapy and assess efficacy? J Eur Acad Dermatol Venereol. 2018. PMID: 30468532. doi:10.1111/jdv.15361
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。